{{Rsnum
|rsid=12569998
|Gene=PTEN
|Chromosome=10
|position=89674157
|Orientation=plus
|GMAF=0.1795
|Gene_s=PTEN
|Assembly=GRCh37.p10
|GenomeBuild=37.5
|dbSNPBuild=138
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
}}
{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 1.8 | 27.4 | 70.8
| HCB | 13.1 | 48.9 | 38.0
| JPT | 10.6 | 46.0 | 43.4
| YRI | 0.0 | 7.5 | 92.5
| ASW | 0.0 | 8.8 | 91.2
| CHB | 13.1 | 48.9 | 38.0
| CHD | 14.7 | 43.1 | 42.2
| GIH | 4.0 | 24.8 | 71.3
| LWK | 2.7 | 23.6 | 73.6
| MEX | 1.7 | 27.6 | 70.7
| MKK | 2.6 | 26.9 | 70.5
| TSI | 2.9 | 10.8 | 86.3
| HapMapRevision=28
}}{{PMID Auto
|PMID=24421178
|Title=PI3K/PTEN/AKT/mTOR pathway genetic variations are associated with the clinical outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment
}}

{{PMID Auto
|PMID=19164214
|Title=Genetic variations in the PI3K/PTEN/AKT/mTOR pathway are associated with clinical outcomes in esophageal cancer patients treated with chemoradiotherapy.
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}